Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMP kinase activation.
Jihyun LimSorim NamJi Hye JeongMin Jung KimYoung YangMyeong-Sok LeeHee Gu LeeJae-Ha RyuJong-Seok LimPublished in: British journal of pharmacology (2019)
Our findings suggest that kazinol U reduces melanogenesis via its inhibitory effect on MITF and its downstream target genes, tyrosinase, Tyrp1 and Tyrp2. This work may provide a basis for the application of kazinol U for the treatment of hyperpigmentation skin disorders.